Fda says cme america recalls bodyguard infusion pump system due to risk of over-, and under-infusion

Fda says cme america recalls bodyguard infusion pump system due to risk of over-, and under-infusion.fda says has identified recall of bodyguard infusion pump systems as a class i recall.fda says there have been 158 complaints regarding bodyguard infusion pump device issue.fda - on jan. 7, cme america, unit of becton dickinson sent letter to distributers & customers informing of bodyguard infusion pump systems issue.fda says use of the affected infusion pumps may cause serious adverse health consequences including death.fda says cme recalled 28,448 devices in the u.s..
BDX Ratings Summary
BDX Quant Ranking